Lv31
240 积分 2023-02-10 加入
Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction： rationale and design of the OPTIMA-6 trial
6个月前
已完结
Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial – update of patient characteristics and study timeline after interim analysis
8个月前
已完结
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
8个月前
已完结
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction
10个月前
已完结
Cardiogenic Shock
10个月前
已完结
Advances in the Management of Cardiogenic Shock
10个月前
已完结
Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI)
1年前
已完结
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
1年前
已完结
Trial of an Intervention to Improve Acute Heart Failure Outcomes
1年前
已完结
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
1年前
已完结
皖公网安备34019202002308
